ADN 240 – Mobility Verified Exam Questions and Answers Latest
update 2026/2027
Question:
Osteoporosis Diagnosis
Answer:
Low bone density
Question:
Osteoporosis Risk Factors
Answer:
Female, family history, thin, lean body build. Age >60, mostpenopausal estrogen deficiency, low
calicitonin, Hx of smoking high alcohol intake (>3 drinks/day), inadequate calcium and vitamin D,
immobility/lack of physical activity, Hx of gastric bypass surgery, high caffeine intake, low BMI
Question:
Secondary Osteoporosis Risk Factors
Answer:
Hyperparathyroidism, hyperthyroidism, diabetes, Cushing's syndrome, anorexia, kidney impairment,
rheumatoid arthritis, malabsorption syndrome, chronic liver disease, inflammatory bowel disease,
celiac disease. Medications (corticosteroids, thyroid medications, loop diuretics, anticonvulsants)
Question:
Osteoporosis Health Promotion/Prevention
Answer:
Adequate calicum and vitamin D before age 35, limit carbonated beverages, sun exposure at least 5-30
min 2x week, weight-bearing activity 30 min 3-5x week
Question:
Osteoporosis Expected Findings
Answer:
Reduced height, acute back pain after lifting or bending, restriction in movement, spinal deformity, Hx
of fractures (wrist, femur, thoracic spine), kyphosis (hunched spine),
, Question:
Osteoporosis Lab Tests
Answer:
DXA scans (bone density, usually done on hip or spine), serum Ca and Phosphorus, 24 hr urine,
peripheral quantitative ultrasound (pQUS) (common in men >70)
Question:
Osteoporosis Medications
Answer:
Thyroid hormone (calcitonin human (SQ), calcitonin salmon (SQ, IM, IN)): inhibit osteoclast activity
Teriparatide: SQ only, parathyroid hormone, stimulates osteoblasts, Ca absorption. Contraindicated in
hypercalcemia, Hx bone caner, raidation, Paet's disease Estrogen Supplements (estrogen,
medroxyprogesterone): replace estrogen loss due to menopause, surgical removal of ovaries. Usually
given w/progesterone Selective Estrogen Receptor Modulators (Raloxifene): decrease osteoclast
activity. avoid in Hx of DVT, monitor liver function Ca Supplement (Ca carbonate, Ca citrate):
promote healthy bones. Give w/food 6-8oz water. Vitamin D Supplement: increases absorption of Ca
from GI tract. Fat soluble (risk for toxicity, weakness , fatigue, nausea, constipation) Biphosphonates
(Alendronate, ibandronate, risedronate, zoledronic acid, pamidronate): decrease number and action of
osteoclasts. Take early morning before eating w/8 oz water. Denosumab: decrease osteoclasts
formation and function, not for clients w/high risk for fractures
Question:
Osteoporosis Complications
Answer:
Fractures (Hip, wrist, spine). Stress importance of dietary intake of Ca, weight bearing activities,
avoid falls (walking on ice/snow)
Question:
Osteoarthritis Diagnosis
Answer:
Progressive non-inflammatory disease of atricular cartilage (noted by tenderness, redness, swelling,
limited ROM, discomfort). Affects synovial joints
Question:
Osteoarthritis Characteristics
Answer:
Usually overweight, not symmetrical, localized inflammation, pain with activity that improves w/rest,
cartilage destruction w/bone spur growth at joint ends (degenerative)
update 2026/2027
Question:
Osteoporosis Diagnosis
Answer:
Low bone density
Question:
Osteoporosis Risk Factors
Answer:
Female, family history, thin, lean body build. Age >60, mostpenopausal estrogen deficiency, low
calicitonin, Hx of smoking high alcohol intake (>3 drinks/day), inadequate calcium and vitamin D,
immobility/lack of physical activity, Hx of gastric bypass surgery, high caffeine intake, low BMI
Question:
Secondary Osteoporosis Risk Factors
Answer:
Hyperparathyroidism, hyperthyroidism, diabetes, Cushing's syndrome, anorexia, kidney impairment,
rheumatoid arthritis, malabsorption syndrome, chronic liver disease, inflammatory bowel disease,
celiac disease. Medications (corticosteroids, thyroid medications, loop diuretics, anticonvulsants)
Question:
Osteoporosis Health Promotion/Prevention
Answer:
Adequate calicum and vitamin D before age 35, limit carbonated beverages, sun exposure at least 5-30
min 2x week, weight-bearing activity 30 min 3-5x week
Question:
Osteoporosis Expected Findings
Answer:
Reduced height, acute back pain after lifting or bending, restriction in movement, spinal deformity, Hx
of fractures (wrist, femur, thoracic spine), kyphosis (hunched spine),
, Question:
Osteoporosis Lab Tests
Answer:
DXA scans (bone density, usually done on hip or spine), serum Ca and Phosphorus, 24 hr urine,
peripheral quantitative ultrasound (pQUS) (common in men >70)
Question:
Osteoporosis Medications
Answer:
Thyroid hormone (calcitonin human (SQ), calcitonin salmon (SQ, IM, IN)): inhibit osteoclast activity
Teriparatide: SQ only, parathyroid hormone, stimulates osteoblasts, Ca absorption. Contraindicated in
hypercalcemia, Hx bone caner, raidation, Paet's disease Estrogen Supplements (estrogen,
medroxyprogesterone): replace estrogen loss due to menopause, surgical removal of ovaries. Usually
given w/progesterone Selective Estrogen Receptor Modulators (Raloxifene): decrease osteoclast
activity. avoid in Hx of DVT, monitor liver function Ca Supplement (Ca carbonate, Ca citrate):
promote healthy bones. Give w/food 6-8oz water. Vitamin D Supplement: increases absorption of Ca
from GI tract. Fat soluble (risk for toxicity, weakness , fatigue, nausea, constipation) Biphosphonates
(Alendronate, ibandronate, risedronate, zoledronic acid, pamidronate): decrease number and action of
osteoclasts. Take early morning before eating w/8 oz water. Denosumab: decrease osteoclasts
formation and function, not for clients w/high risk for fractures
Question:
Osteoporosis Complications
Answer:
Fractures (Hip, wrist, spine). Stress importance of dietary intake of Ca, weight bearing activities,
avoid falls (walking on ice/snow)
Question:
Osteoarthritis Diagnosis
Answer:
Progressive non-inflammatory disease of atricular cartilage (noted by tenderness, redness, swelling,
limited ROM, discomfort). Affects synovial joints
Question:
Osteoarthritis Characteristics
Answer:
Usually overweight, not symmetrical, localized inflammation, pain with activity that improves w/rest,
cartilage destruction w/bone spur growth at joint ends (degenerative)
